UK markets closed

Cidara Therapeutics, Inc. (CDTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
12.69+0.27 (+2.17%)
At close: 04:00PM EDT
12.69 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate-4.1-5.05-17.49-8.67
Low estimate-4.1-5.05-17.49-8.67
High estimate-4.1-5.05-17.49-8.67
Year ago EPS-2.8-1.8-5.2-17.49
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate4.7M5.4M25.75M10.7M
Low estimate1.3M1.3M12.2MN/A
High estimate8.1M9.5M39.3M21.4M
Year ago salesN/AN/A63.91M25.75M
Sales growth (year/est)N/AN/A-59.70%-58.40%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-2.6-3.25-2.07-0.2
Actual EPS-2.8-1.8-0.8-2.28
Difference-0.21.451.27-2.08
Surprise %-7.70%44.60%61.40%-1,040.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-4.1-5.05-17.49-8.67
7 days ago-4.1-5.05-17.49-8.67
30 days ago-0.19-0.26-0.96-1.33
60 days ago-0.13-0.16-0.58-0.13
90 days ago-0.13-0.16-0.58-0.13
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCDTXIndustrySector(s)S&P 500
Current qtr.-46.40%N/AN/AN/A
Next qtr.-180.60%N/AN/AN/A
Current year-236.30%N/AN/AN/A
Next year50.40%N/AN/AN/A
Next 5 years (per annum)61.20%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A